- Home
- TSSI vs TARA Comparison
TSSI vs TARA Comparison
Compare TSSI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TSSI | TARA |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | 161 | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.9M | 268.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | TSSI | TARA |
|---|---|---|
| Price | $13.95 | $5.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $16.00 | ★ $21.67 |
| AVG Volume (30 Days) | ★ 1.7M | 744.0K |
| Earning Date | 03-11-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.39 | N/A |
| P/E Ratio | $42.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.63 | $2.77 |
| 52 Week High | $31.94 | $7.82 |
Technical Indicators
Market Signals| Indicator | TSSI | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 65.65 | 40.68 |
| Support Level | $7.23 | $4.95 |
| Resistance Level | $16.28 | $5.39 |
| Average True Range (ATR) | 1.15 | 0.29 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 88.70 | 30.43 |
Price Performance
Historical ComparisonAbout TSSI TSS Inc.
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).